Miromatrix Stock Analysis

MIRO -  USA Stock  

USD 10.41  0.29  2.87%

The big decline in price over the last few months for Miromatrix Medicalmay encourage institutional investors to take a closer look at the firm as it is trading at a share price of 10.41 on very low momentum in trading volume. The company directors and management failed to add value to investors and positioning the firm supply of money to exploit market volatility in June. However, diversifying your holdings with Miromatrix Medical or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 6.34. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Miromatrix Medical partners.
Additionally, see Stocks Correlation.

Search Stock Analysis 

The Miromatrix Medical stock analysis report makes it easy to digest most publicly released information about Miromatrix Medical and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Miromatrix Stock analysis module also helps to analyze the Miromatrix Medical price relationship with some important fundamental indicators such as market cap and management efficiency.

Miromatrix Stock Analysis Notes

The company had not issued any dividends in recent years.

Miromatrix Medical Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Miromatrix Medical's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Miromatrix Medical or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Miromatrix Medical generates negative expected return over the last 90 days
Miromatrix Medical has high historical volatility and very poor performance
Miromatrix Medical has high likelihood to experience some financial distress in the next 2 years
Miromatrix Medical has a frail financial position based on the latest SEC disclosures
Latest headline from www.equities.com: Miromatrix Medical falls 2.78 percent in Light Trading on July 26 - Equities.com

Miromatrix Medical SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Miromatrix Medical prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Miromatrix Medical investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Miromatrix Medical specific information freely available to individual and institutional investors to make a timely investment decision.
28th of June 2021
Financial Statements and Exhibits. Other Events. Amendments to Articles of Incorporation or Bylaws; and/or Change in Fiscal Year. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Miromatrix Profitablity

Miromatrix Medical's profitability indicators refer to fundamental financial ratios that showcase Miromatrix Medical's ability to generate income relative to its revenue or operating costs. If, let's say, Miromatrix Medical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Miromatrix Medical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Miromatrix Medical's profitability requires more research than a typical breakdown of Miromatrix Medical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2021
Return on Average Assets(1.43) (1.54) 
Return on Average Equity 0.22  0.20 
Return on Invested Capital(4.35) (4.69) 
Return on Sales(207.46) (212.92) 

Management Efficiency

The value of Return on Average Assets is estimated to slide to -1.54. The value of Return on Average Equity is estimated to slide to 0.20. Miromatrix Medical Total Assets are quite stable at the moment as compared to the past year. The company's current value of Total Assets is estimated at 5.5 Million. Current Assets is expected to rise to about 4.9 M this year, although the value of Asset Turnover will most likely fall to 0.006263. Miromatrix Medical management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.
Last ReportedProjected for 2021
Book Value per Share(23.57) (25.43) 
Tangible Assets Book Value per Share 2.43  2.59 
Tangible Asset Value5.3 M5.5 M

Technical Drivers

As of the 30th of July, Miromatrix Medical secures the mean deviation of 2.78, and Risk Adjusted Performance of (0.1). In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Miromatrix Medical, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We were able to interpolate data for nineteen technical drivers for Miromatrix Medical, which can be compared to its peers in the industry. Please verify Miromatrix Medical variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Miromatrix Medical is priced some-what accurately, providing market reflects its recent price of 10.41 per share. Given that Miromatrix Medical has jensen alpha of (0.72), we recommend you to check Miromatrix Medical's last-minute market performance to make sure the company can sustain itself at a future point.

Miromatrix Medical Price Movement Analysis

The output start index for this execution was four with a total number of output elements of twenty-two. The Mid-point over period is an average of Miromatrix Medical highest and lowest values attained during the given period. View also all equity analysis or get more info about midpoint over period overlap studies indicator.

Miromatrix Medical Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Miromatrix Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Miromatrix Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Miromatrix Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Miromatrix Medical Technical and Predictive Indicators

Miromatrix Medical Forecast Models

Miromatrix Medical time-series forecasting models is one of many Miromatrix Medical's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Miromatrix Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Miromatrix Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Miromatrix Medical stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Miromatrix shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Miromatrix Medical. By using and applying Miromatrix Stock analysis, traders can create a robust methodology for identifying Miromatrix entry and exit points for their positions.
Last ReportedProjected for 2021
EBITDA Margin(13.16) (14.19) 
Gross Margin(8.77) (9.46) 
Profit Margin(14.57) (15.72) 

Current Miromatrix Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Miromatrix analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Miromatrix analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
22.0Strong Buy1Odds
Miromatrix Medical current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Miromatrix analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Miromatrix stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Miromatrix Medical, talking to its executives and customers, or listening to Miromatrix conference calls.
Miromatrix Analyst Advice Details

Miromatrix Stock Analysis Indicators

Miromatrix Medical stock analysis indicators help investors evaluate how Miromatrix Medical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Miromatrix Medical shares will generate the highest return on investment. By understating and applying Miromatrix Medical stock analysis, traders can identify Miromatrix Medical position entry and exit signals to maximize returns.
Fifty Two Week Low10.96
Fifty Two Week High16.52
Average Daily Volume Last 10 Day2.02M
Average Daily Volume In Three Month2.02M
Fifty Day Average13.99
Two Hundred Day Average13.99
Additionally, see Stocks Correlation. Note that the Miromatrix Medical information on this page should be used as a complementary analysis to other Miromatrix Medical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for Miromatrix Stock analysis

When running Miromatrix Medical price analysis, check to measure Miromatrix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Miromatrix Medical is operating at the current time. Most of Miromatrix Medical's value examination focuses on studying past and present price action to predict the probability of Miromatrix Medical's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Miromatrix Medical's price. Additionally, you may evaluate how the addition of Miromatrix Medical to your portfolios can decrease your overall portfolio volatility.
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Global Correlations
Find global opportunities by holding instruments from different markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Fundamental Analysis
View fundamental data based on most recent published financial statements
The market value of Miromatrix Medical is measured differently than its book value, which is the value of Miromatrix that is recorded on the company's balance sheet. Investors also form their own opinion of Miromatrix Medical's value that differs from its market value or its book value, called intrinsic value, which is Miromatrix Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Miromatrix Medical's market value can be influenced by many factors that don't directly affect Miromatrix Medical underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Miromatrix Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine Miromatrix Medical value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Miromatrix Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.